Liver Damage in Type 1 Diabetes Mellitus

by A. O. Bueverov, A. V. Zilov
Published 2021-06-01

Predicting the outcome of myocardial infarction in elderly and senile patients with type 2 diabetes

by A. L. Terekhova, A. V. Zilov, G. А. Melnichenko, А. L. Vertkin
Published 2015-12-01

The prevalence and risk factors of diabetic polyneuropathy in inpatients with type 1 diabetes

by I. A. Strokov, G. A. Melnichenko, Zh. S. Albekova, A. V. Zilov, L. T. Akhmedzhanova
Published 2015-02-01

Comparison of effects of carbohydrate metabolism compensation and atorvastatin treatment on lipid metabolism and C-reactive protein in type 2 diabetes mellitus

by I V Glinkina, A V Zilov, G A Mel'nichenko, A P Roytman, A V Il'in, I V Glinkina, A V Zilov, G A Melnichenko, A P Roitman, A V Ilyin
Published 2008-12-01

Immunoresistance syndrome in gout patients and its influence on formation of clinical features of the disease

by V G Barskova, M S Eliseev, E L Nasonov, I A Yakunina, A V Zilov, E V Ilyinykh
Published 2004-05-01

THE USE OF ULTRA-LONG-ACTING INSULIN ANALOGUE DEGLUDEC IN TYPE 1 DIABETES MELLITUS IN CLINICAL PRACTICE: THE INFLUENCE ON QUALITY OF LIFE AND SATISFACTION WITH TREATMENT

by M. F. Kalashnikova, D. R. Yazykova, N. V. Likhodey, A. V. Zilov, Yu. P. Sych, E. S. Maloletkina, V. V. Fadeev
Published 2016-12-01